Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Bonekey Reports|November 21, 2015
Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitroCyril Thouverey, Joseph CaverzasioJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 9, 2015
Suppression of p38α MAPK Signaling in Osteoblast Lineage Cells Impairs Bone Anabolic Action of Parathyroid HormoneCyril Thouverey, Joseph CaverzasioCellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|April 8, 2011
Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growthJoseph Caverzasio, Cyril ThouvereyBonekey Reports|July 2, 2015
Focus on the p38 MAPK signaling pathway in bone development and maintenanceCyril Thouverey, Joseph CaverzasioCellular and Molecular Life Sciences : CMLS|April 25, 2012
The p38α MAPK positively regulates osteoblast function and postnatal bone acquisitionCyril Thouverey, Joseph CaverzasioEndocrinology|October 7, 2015
Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen DeficiencyCyril Thouverey, Joseph CaverzasioBone|May 12, 2018
Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in miceCyril Thouverey, Serge Ferrari, Joseph CaverzasioJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 29, 2012
Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferationJoseph Caverzasio, Emmanuel Biver, Cyril ThouvereyMolecular and Cellular Endocrinology|September 25, 2013
Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cellsEmmanuel Biver, Cyril Thouverey, David Magne, et al.JCI Insight|May 7, 2024
Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cellsCyril Thouverey, Pierre Apostolides, Julia Brun, et al.Pageof 4